Platinum Industries Ltd Q2 FY2027 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/0hyjdwigmcesoegkcsm534oc.pdf

Key Takeaways


Egypt Facility: The Strategic Pivot

Krishna Rana: "Despite a dynamic macro environment and shifting global supply chain currents, Platinum Industries has continued to reinforce its position as a leading player in PVC stabilizers, lubricants and speciality chemicals."

Profitability & Margin Recovery Path

Ashok Bothra: "The volatility in our profitability reflects the ongoing transition and ramp-up phases of our expanded manufacturing facility, as well as a temporary lower share of high-margin products like lead-free PVC and surging Ocean Freight in first half of FY 27."

Domestic Demand & Industry Context


New Initiatives & Diversification


Guidance & Commitments

CommitmentSpecificsTimeline
Egypt partial capacity startStabilizer production commences; initial capacity of 30,000 MTPA31st December 2026
Egypt full capacity commissioningRemaining capacity to be commissioned31st March 2027
Egypt FY27 revenue contribution₹25–30 crores from Jan–Mar salesFY27 (2.5 months of operations)
Egypt meaningful contributionSignificantly strengthening export mix and long-term margin profileFY28 onwards
Palghar utilization targetCross ~50% utilizationWithin 2 years
EBITDA margin recoveryReturn to 13–15% range and maintain year-on-yearNot specified
3-year revenue CAGR35% CAGR target reiteratedOver 3 years
Korglutide revenue startRevenue expected from nutraceutical product salesQ1 FY28 (Pharma)
Margin decline recoveryCover up margin declineNext two quarters

Key Metrics

MetricQ2 FY27
Consolidated revenue₹121.3 cr, +23.3% YoY
Standalone revenue₹120 cr, +23.9% YoY
Consolidated EBITDA₹10.8 cr, margin 8.9% vs 13.8% in Q2 FY26
Standalone EBITDA₹10.5 cr, margin 8.8% vs 14.6% in Q2 FY26
Consolidated PAT₹7.6 cr, vs ₹11 cr in Q2 FY26
Standalone PAT₹7.8 cr, vs ₹12.1 cr in Q2 FY26
Consolidated EPS₹1.40 per share, basic and diluted
H1 FY27 consolidated revenue₹230.20 cr, +7.7% YoY
H1 FY27 consolidated EBITDA margin10.5%, vs 13.4% in H1 FY26
H1 FY27 consolidated PAT₹18.7 cr, vs ₹24.1 cr in H1 FY26
Oleochemicals segment sales₹11.4 cr in Q2, ₹16.7 cr in H1 FY27
Export revenue₹24 cr, +40% YoY; Q1 FY27 was ₹22 cr
Export logistics cost₹5 cr, doubled from ₹2.5 cr in Q1 FY27
Palghar facility utilization30–35%
Egypt plant expected FY27 revenue₹25–30 cr, from Jan–Mar sales (2.5 months)
Egypt plant missed sales (3–4 months)₹30–35 cr
Lead-free stabilizer margin decline (H1 FY27 vs H1 FY26)3–4%
CPVC margin decline QoQ1–2%
3-year CAGR target35%
EBITDA margin target13–15% year on year